Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma

Published:2009-12 Issue:6 Volume:250 Page:950-956
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Murakami Yoshiaki,Uemura Kenichiro,Sudo Takeshi,Hayashidani Yasuo,Hashimoto Yasushi,Nakamura Hiroyuki,Nakashima Akira,Sueda Taijiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference53 articles.

1. Cancer statistics, 2008.;Jemal;CA Cancer J Clin,2008

2. Chemotherapy for biliary tract cancer in Japan.;Okusaka;Semin Oncol,2002

3. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.;Nagino;Ann Surg,2006

4. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.;Yoshida;Arch Surg,2002

5. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification.;Shimizu;J Hepatobiliary Pancreat Surg,2007

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transmembrane serine protease 4 expression in the prognosis of radical resection for biliary tract cancer;World Journal of Gastrointestinal Surgery;2024-08-27

2. Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer;Langenbeck's Archives of Surgery;2023-11-24

3. Prognostic impact of lung recurrence in patients with biliary tract cancer;Langenbeck's Archives of Surgery;2023-07-31

4. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study;Journal of Gastrointestinal Surgery;2023-02-07

5. Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy;HPB;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3